Cheli Melzer Cohen (Cheli Melzer-Cohen)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Low Density Lipoprotein

Hypertrophic Cardiomyopathy

Chronic Kidney Disease

Top Venues

Diabetes, obesity & metabolism

Journal of clinical medicine

Clinical journal of the American Society of Nephrology : CJASN

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Afif Nakhleh, Muhammad A Abdul-Ghani, Sivan Gazit, Adi Gross, Idit Livnat, Maya Greenbloom, Adva Yarden, Khaled Khazim, Naim Shehadeh, Cheli Melzer Cohen
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria. Diabetes, obesity & metabolism 26 (8) (2024)
Afif Nakhleh, Muhammad A Abdul-Ghani, Sivan Gazit, Adi Gross, Idit Livnat, Maya Greenbloom, Adva Yarden, Khaled Khazim, Naim Shehadeh, Cheli Melzer Cohen
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria. Diabetes, obesity & metabolism (2024)
Cheli Melzer Cohen, Meir Schechter, Aliza Rozenberg, Ilan Yanuv, Dvora R Sehtman-Shachar, Alisa Fishkin, Doron Rosenzweig, Gabriel Chodick, Avraham Karasik, Lawrence A Leiter
Long-Term, Real-World, Kidney Function Changes with SGLT2i versus DPP4i Type 2 Diabetes without Cardiovascular or Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN (2023)
Avishay Elis, Cheli Melzer Cohen, Gabriel Chodick
Real-World Use of Alirocumab: Experience from a Large Healthcare Provider. Journal of clinical medicine 12 (3) (2023)
Avishay Elis, Cheli Melzer Cohen, Gabriel Chodick
Real-World Use of Alirocumab: Experience from a Large Healthcare Provider. Journal of clinical medicine 12 (3) (2023)
Cheli Melzer Cohen, Meir Schechter, Aliza Rozenberg, Ilan Yanuv, Dvora R Sehtman-Shachar, Alisa Fishkin, Doron Rosenzweig, Gabriel Chodick, Avraham Karasik, Lawrence A Leiter
Long-Term, Real-World, Kidney Function Changes with SGLT2i versus DPP4i Type 2 Diabetes without Cardiovascular or Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN (2023)
Meir Schechter, Cheli Melzer Cohen, Tamir Zelter, Ilan Yanuv, Aliza Rozenberg, Gabriel Chodick, Avraham Karasik, Lawrence A Leiter
Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real-world data. Diabetes, obesity & metabolism (2023)
Avishay Elis, Cheli Melzer Cohen, Gabriel Chodick
Real-World Use of Alirocumab: Experience from a Large Healthcare Provider. Journal of clinical medicine 12 (3) (2023)
Inbar Zucker, Yair Zloof, Aya Bardugo, Avishai Michael Tsur, Miri Lutski, Yaron Cohen, Tali Cukierman-Yaffe, Noga Minsky, Estela Derazne, Dorit Tzur, Cheli Melzer Cohen, Orit Pinhas-Hamiel, Gabriel Chodick, Itamar Raz, Arnon Afek, Ulagamadesan Venkatesan, Amir Tirosh, Gilad Twig
Obesity in late adolescence and incident type 1 diabetes in young adulthood. Diabetologia 65 (9) (2022)
Cheli Melzer Cohen, Nino Hallén, Gabriel Chodick, Lotmit Bourvine, Tal Waner, Avraham Karasik
Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort Study. PharmacoEconomics - open 5 (3) (2021)
Carolyn Su Ping Lam, Avraham Karasik, Cheli Melzer Cohen, Matthew A Cavender, Shun Kohsaka, Anna Norhammar, Marcus Thuresson, Hungta Chen, Eric T Wittbrodt, Peter Fenici, Mikhail Kosiborod, null null
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study. Diabetes, obesity & metabolism 23 (6) (2021)
Cheli Melzer Cohen, Tamar Banon, Varda Shalev, Gabriel Chodick
The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real-world data in Israel. Endocrinology, diabetes & metabolism 3 (3) (2020)